Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs

Corrado Girmenia1, Wilma Barcellini2, Paola Bianchi2

  • 1Hematology, Department of Hematology, Oncology and Dermatology, AOU Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.

Blood Reviews
|September 18, 2022
PubMed

Insights

Experts identified key unmet needs in managing infectious risks for paroxysmal nocturnal hemoglobinuria (PNH) patients on complement inhibitors (CIs). Recommendations focus on enhancing infection prevention and non-pharmacological strategies for better CI therapy outcomes.

Area of Science:

  • Hematology
  • Immunology
  • Clinical Medicine

Background:

  • Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired blood disorder.
  • Terminal complement inhibitors (CIs) like eculizumab are effective PNH treatments.
  • Infectious complications pose a significant risk for PNH patients on CIs.

Purpose of the Study:

  • To identify and address unmet clinical needs (UCNs) in managing infectious risk in PNH patients.
  • To establish consensus on optimizing infection prevention and management strategies.
  • To propose advancements in clinical practice for complement inhibitor therapy.

Main Methods:

  • A panel of experts was convened to discuss UCNs using the Delphi technique.
  • Clinically relevant UCNs for PNH patients receiving or considering CIs were selected.
  • Consensus opinions and proposals for clinical practice were developed.

Main Results:

  • Key UCNs identified include optimizing infection prevention measures.
  • Developing non-pharmacological infectious risk-mitigation strategies is crucial.
  • Improving the management of disease exacerbation during infectious complications is needed.

Conclusions:

  • Addressing these UCNs can improve the safety and efficacy of CI therapy in PNH.
  • The findings will inform future clinical practice and research in PNH management.
  • Enhanced strategies are needed to mitigate infectious risks associated with CIs.

Related Concept Videos

Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
23
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
36
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
34
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
430
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K